AU583489B2 - 8alpha-acylamino-ergolines uses and production thereof - Google Patents

8alpha-acylamino-ergolines uses and production thereof

Info

Publication number
AU583489B2
AU583489B2 AU37609/85A AU3760985A AU583489B2 AU 583489 B2 AU583489 B2 AU 583489B2 AU 37609/85 A AU37609/85 A AU 37609/85A AU 3760985 A AU3760985 A AU 3760985A AU 583489 B2 AU583489 B2 AU 583489B2
Authority
AU
Australia
Prior art keywords
8alpha
ergolines
acylamino
production
ergolines uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU37609/85A
Other languages
English (en)
Other versions
AU3760985A (en
Inventor
Walter Haefliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU3760985A publication Critical patent/AU3760985A/en
Application granted granted Critical
Publication of AU583489B2 publication Critical patent/AU583489B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU37609/85A 1984-01-12 1985-01-11 8alpha-acylamino-ergolines uses and production thereof Ceased AU583489B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3400853 1984-01-12
DE3400853 1984-01-12

Related Child Applications (2)

Application Number Title Priority Date Filing Date
AU25067/88A Division AU618290B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline
AU25066/88A Division AU609539B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline

Publications (2)

Publication Number Publication Date
AU3760985A AU3760985A (en) 1985-07-18
AU583489B2 true AU583489B2 (en) 1989-05-04

Family

ID=6224786

Family Applications (3)

Application Number Title Priority Date Filing Date
AU37609/85A Ceased AU583489B2 (en) 1984-01-12 1985-01-11 8alpha-acylamino-ergolines uses and production thereof
AU25067/88A Ceased AU618290B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline
AU25066/88A Ceased AU609539B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU25067/88A Ceased AU618290B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline
AU25066/88A Ceased AU609539B2 (en) 1984-01-12 1988-11-11 A novel 8alpha-acylaminoergoline

Country Status (28)

Country Link
US (2) US4950672A (OSRAM)
JP (1) JPH0655739B2 (OSRAM)
AT (1) AT391317B (OSRAM)
AU (3) AU583489B2 (OSRAM)
BE (1) BE901456A (OSRAM)
CA (1) CA1245640A (OSRAM)
CH (1) CH664568A5 (OSRAM)
CY (1) CY1542A (OSRAM)
DE (1) DE3500251C2 (OSRAM)
DK (1) DK169891B1 (OSRAM)
ES (1) ES8605514A1 (OSRAM)
FI (1) FI82466C (OSRAM)
FR (1) FR2560196B1 (OSRAM)
GB (1) GB2152507B (OSRAM)
GR (1) GR850065B (OSRAM)
HK (1) HK48590A (OSRAM)
HU (1) HU197569B (OSRAM)
IE (1) IE58228B1 (OSRAM)
IL (1) IL74043A (OSRAM)
IT (1) IT1214648B (OSRAM)
LU (1) LU85725A1 (OSRAM)
NL (1) NL193541C (OSRAM)
NZ (1) NZ210818A (OSRAM)
PH (1) PH23286A (OSRAM)
PT (1) PT79818B (OSRAM)
SE (1) SE460420B (OSRAM)
SG (1) SG32390G (OSRAM)
ZA (1) ZA85276B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
EP0160842B1 (de) * 1984-04-09 1994-06-22 Schering Aktiengesellschaft 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
HUT45248A (en) * 1986-01-24 1988-06-28 Sandoz Ag Process for producing 8alpha-(acylamino)-ergoline derivatives and pharmaceuticals comprising such compounds
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
US4981859A (en) * 1987-06-15 1991-01-01 Cycloalkylamides of (8 beta )-1-alkyl-6-(substituted)ergolines
DE3820159A1 (de) * 1987-06-23 1989-01-05 Sandoz Ag 8(alpha)-acylaminoergolin, seine herstellung und dieses enthaltende arzneimittel
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE3915950A1 (de) * 1989-05-12 1990-11-15 Schering Ag 8(alpha)-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
MX2017009406A (es) 2015-01-20 2018-01-18 Xoc Pharmaceuticals Inc Compuestos de tipo isoergolina y usos de estos.
BR112017015487A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
MX2019014272A (es) 2017-06-01 2020-12-11 Xoc Pharmaceuticals Inc Compuestos policiclicos y usos de los mismos.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU505314B2 (en) * 1974-07-19 1979-11-15 Sandoz Ltd. Ergoline derivatives
AU514288B2 (en) * 1975-12-23 1981-02-05 Sandoz Ltd. Ergoline derivatives
AU547647B2 (en) * 1980-09-23 1985-10-31 Sandoz Ltd. Preparation of 8alpha substituted ergoline

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218323A (en) * 1965-11-16 Esters of i,g-dimethyl-b-ergolenyl carbamic acid
US2864822A (en) * 1956-10-22 1958-12-16 Lilly Co Eli 9-amino-7-methyl-belta10-ergolene and derivatives thereof
CH622519A5 (en) * 1974-07-05 1981-04-15 Hoechst Ag Process for the preparation of hydroxyalkylxanthines
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
CH622518A5 (en) * 1976-12-14 1981-04-15 Sandoz Ag Process for the preparation of novel ergoline compounds
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
HU197569B (en) * 1984-01-12 1989-04-28 Sandoz Ag Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
IT1219652B (it) * 1987-06-23 1990-05-24 Sandoz Ag 8-acilamminoergolina,la sua preparazione e il suo impiego come medicamneto

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU505314B2 (en) * 1974-07-19 1979-11-15 Sandoz Ltd. Ergoline derivatives
AU514288B2 (en) * 1975-12-23 1981-02-05 Sandoz Ltd. Ergoline derivatives
AU547647B2 (en) * 1980-09-23 1985-10-31 Sandoz Ltd. Preparation of 8alpha substituted ergoline

Also Published As

Publication number Publication date
PT79818B (en) 1987-01-07
GR850065B (OSRAM) 1985-05-03
JPH0655739B2 (ja) 1994-07-27
CH664568A5 (de) 1988-03-15
GB2152507A (en) 1985-08-07
IL74043A (en) 1988-10-31
NL193541C (nl) 2000-01-04
LU85725A1 (fr) 1985-10-22
PT79818A (en) 1985-02-01
PH23286A (en) 1989-06-30
NL8500008A (nl) 1985-08-01
FI850130A0 (fi) 1985-01-11
JPS60174783A (ja) 1985-09-09
ZA85276B (en) 1986-08-27
HK48590A (en) 1990-06-29
ES8605514A1 (es) 1986-03-16
IT1214648B (it) 1990-01-18
IL74043A0 (en) 1985-04-30
HU197569B (en) 1989-04-28
FI82466B (fi) 1990-11-30
GB8500454D0 (en) 1985-02-13
FI82466C (fi) 1991-03-11
NL193541B (nl) 1999-09-01
DK12685A (da) 1985-07-13
CA1245640A (en) 1988-11-29
FR2560196A1 (fr) 1985-08-30
SG32390G (en) 1990-08-03
US5077298A (en) 1991-12-31
DK12685D0 (da) 1985-01-10
HUT37148A (en) 1985-11-28
AT391317B (de) 1990-09-25
IT8547538A0 (it) 1985-01-11
AU618290B2 (en) 1991-12-19
ATA5985A (de) 1990-03-15
SE8500107D0 (sv) 1985-01-10
SE460420B (sv) 1989-10-09
AU2506788A (en) 1989-03-02
CY1542A (en) 1991-03-22
IE58228B1 (en) 1993-08-11
GB2152507B (en) 1987-07-15
DK169891B1 (da) 1995-03-27
ES539511A0 (es) 1986-03-16
AU2506688A (en) 1989-02-23
IE850064L (en) 1985-07-12
SE8500107L (sv) 1985-07-13
DE3500251A1 (de) 1985-07-18
BE901456A (fr) 1985-07-08
AU3760985A (en) 1985-07-18
AU609539B2 (en) 1991-05-02
DE3500251C2 (de) 1995-01-26
FI850130L (fi) 1985-07-13
FR2560196B1 (fr) 1986-07-18
NZ210818A (en) 1989-02-24
US4950672A (en) 1990-08-21

Similar Documents

Publication Publication Date Title
AU577632B2 (en) Labels and manufacture thereof
AU3839785A (en) Sammelpackung
AU4254685A (en) Arylhydroxamates
AU3476789A (en) Benzothiazolones and their production
AU4256585A (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones
AU578776B2 (en) Novel beta-lactams and their production
AU3749685A (en) Induktionsmotor
AU4105285A (en) Tetrahydrofuran-2-ylmethylamines
AU4061285A (en) Schaltersicherungseinheit
AU583489B2 (en) 8alpha-acylamino-ergolines uses and production thereof
AU4752785A (en) 13-halo and 13 hydroxymilbemycins
AU569601B2 (en) Microknit explosive and production thereof
AU568750B2 (en) Imidazo-pyrrolo-pyridines and their use as herbacides
AU4061585A (en) Automatisk fadolsaftapningsanlaeg
AU4271085A (en) Metallophosphoaluminates
AU584195B2 (en) Isocyanate compounds and their production
AU4216685A (en) Aminocarnitines
AU2759988A (en) Beta-hydroxyketone and its production
AU3067684A (en) Helicoplane
AU4001785A (en) Substituted isochromanes and oxepines
AU7677087A (en) Dipropargyloxybenzene compounds and their production
AU4200785A (en) Diamino - 6 - halogeno - 5 - alkylthio-pyrimidines
AU4271185A (en) Ferrophosphoaluminates
AU3884285A (en) Heibmangel
AU589241B2 (en) Dipropargyloxybenzene compounds and their production

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired